Mylan NL CEO Heather Bresch waits to testify before a House Oversight and Government Reform Committee hearing on Rising Price of EpiPens at the Capitol in Washington, U.S. September 21, 2016. REUTERS/Yuri Gripas  - RTSOUBL

Mylan NL CEO Heather Bresch waits to testify before a House Oversight and Government Reform Committee hearing on Rising Price of EpiPens at the Capitol in Washington, U.S. September 21, 2016. REUTERS/Yuri Gripas - RTSOUBL

Senate Panel Urges FTC to Launch Mylan Antitrust Probe

Markets